Literature DB >> 26228294

A convenient screening method to differentiate phenolic skin whitening tyrosinase inhibitors from leukoderma-inducing phenols.

Shosuke Ito1, Kazumasa Wakamatsu2.   

Abstract

BACKGROUND: Tyrosinase is able to oxidize a great number of phenols and catechols to form ortho-quinones. Ortho-quinones are highly reactive compounds that exert cytotoxicity through binding with thiol enzymes and the production of reactive oxygen species. Certain phenolic (and catecholic) compounds are known to induce contact/occupational leukoderma through activation to ortho-quinones.
OBJECTIVE: We report a convenient screening method to follow the oxidation of those leukoderma-inducing phenols by mushroom tyrosinase.
METHODS: Oxidation of phenolic compounds by mushroom tyrosinase was followed periodically by UV-vis spectrophotometry. The production of ortho-quinones were confirmed by their absorptions around 400-420 nm. HPLC analysis after reduction with NaBH4 detected the corresponding catechols.
RESULTS: Leukoderma-inducing phenols, rhododendrol, raspberry ketone, 4-methoxyphenol, 4-benzyloxyphenol, 4-tert-butylphenol, and 4-tert-butylcatechol, were readily oxidized by mushroom tyrosinase to form ortho-quinones. On the other hand, phenolic skin whitening tyrosinase inhibitors, ellagic acid, 4-n-butylresorcinol, potassium 4-methoxysalicylate, and 2,2'-dihydroxy-5,5'-di-n-propylbiphenyl, were not oxidized by mushroom tyrosinase, while arbutin was only slowly oxidized.
CONCLUSION: This study has provided a convenient screening method to differentiate phenolic skin whitening tyrosinase inhibitors from leukoderma-inducing phenols. A common chemical feature of the latter group of compounds is that they are readily oxidized by tyrosinase to form reactive ortho-quinone species. The present results point out the necessity that tyrosinase inhibitors should also be examined as substrates if they are phenolic compounds.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Melanocyte toxicity; Rhododendrol; Tyrosinase; Tyrosinase inhibitor; Whitening agent

Mesh:

Substances:

Year:  2015        PMID: 26228294     DOI: 10.1016/j.jdermsci.2015.07.007

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  7 in total

1.  Large-Scale Recombinant Expression and Purification of Human Tyrosinase Suitable for Structural Studies.

Authors:  Xuelei Lai; Montserrat Soler-Lopez; Harry J Wichers; Bauke W Dijkstra
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

Review 2.  Biochemical Mechanism of Rhododendrol-Induced Leukoderma.

Authors:  Shosuke Ito; Kazumasa Wakamatsu
Journal:  Int J Mol Sci       Date:  2018-02-12       Impact factor: 5.923

3.  Protocatechuic Aldehyde Inhibits α-MSH-Induced Melanogenesis in B16F10 Melanoma Cells via PKA/CREB-Associated MITF Downregulation.

Authors:  Seok-Chun Ko; Seung-Hong Lee
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

4.  Assessing the Morphological and Behavioral Toxicity of Catechol Using Larval Zebrafish.

Authors:  Michael G Morash; Kelly H Soanes; John C Achenbach; Lee D Ellis
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

5.  The Metabolic Fate of ortho-Quinones Derived from Catecholamine Metabolites.

Authors:  Shosuke Ito; Yuta Yamanaka; Makoto Ojika; Kazumasa Wakamatsu
Journal:  Int J Mol Sci       Date:  2016-01-27       Impact factor: 5.923

6.  Conjugation with Dihydrolipoic Acid Imparts Caffeic Acid Ester Potent Inhibitory Effect on Dopa Oxidase Activity of Human Tyrosinase.

Authors:  Raffaella Micillo; Julia Sirés-Campos; José Carlos García-Borrón; Lucia Panzella; Alessandra Napolitano; Conchi Olivares
Journal:  Int J Mol Sci       Date:  2018-07-24       Impact factor: 5.923

Review 7.  Chemical Reactivities of ortho-Quinones Produced in Living Organisms: Fate of Quinonoid Products Formed by Tyrosinase and Phenoloxidase Action on Phenols and Catechols.

Authors:  Shosuke Ito; Manickam Sugumaran; Kazumasa Wakamatsu
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.